- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Sanofi India Secures Relief as Tax Authority Drops Rs 72.71 Lakh Demand

Mumbai: Sanofi India Limited has received a favourable order from the Commissioner of Income Tax (Appeals)-49, Mumbai, resulting in the deletion of a tax demand amounting to Rs 72.71 lakh for Assessment Year 2019-20.
In a regulatory disclosure, the pharmaceutical company informed the stock exchanges that the appellate authority had accepted its submissions and dropped proceedings initiated under Section 201 of the Income-tax Act, 1961. The company received the order on July 2, 2026.
The matter arose after Sanofi India was treated as an “assessee in default” for alleged non-deduction of taxes on year-end provisions, leading to a demand of ₹72,71,510. The company subsequently challenged the order before the Commissioner of Income Tax (Appeals).
According to the company, the appellate authority accepted its contention that the corresponding amount had already been disallowed in its tax computation. Therefore, the company could not be treated as an assessee in default under Section 201(1) for the same amount and subjected to additional demand and interest.
Consequently, the Commissioner of Income Tax (Appeals) issued an order in favour of the company and dropped the proceedings under Section 201 for Assessment Year 2019-20.
Sanofi India further stated that the order will have no material impact on its financial, operational or other activities.
M. Pharm (Pharmaceutics)
Parthika Patel has completed her Graduated B.Pharm from SSR COLLEGE OF PHARMACY and done M.Pharm in Pharmaceutics. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

